{"id":347032,"date":"2025-08-25T11:08:26","date_gmt":"2025-08-25T11:08:26","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-agilon-health\/"},"modified":"2025-08-25T11:08:26","modified_gmt":"2025-08-25T11:08:26","slug":"how-to-buy-agilon-health","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/","title":{"rendered":"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-347032","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - AGL Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - AGL Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Agilon Health (AGL) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenin, mevcut 1,33 $ hisse fiyat\u0131n\u0131 analiz edin ve bu de\u011fer odakl\u0131 bak\u0131m alan\u0131ndaki sa\u011fl\u0131k inovasyoncusu i\u00e7in yat\u0131r\u0131m stratejilerini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Agilon Health (AGL) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenin, mevcut 1,33 $ hisse fiyat\u0131n\u0131 analiz edin ve bu de\u011fer odakl\u0131 bak\u0131m alan\u0131ndaki sa\u011fl\u0131k inovasyoncusu i\u00e7in yat\u0131r\u0131m stratejilerini ke\u015ffedin."},"intro":"Sa\u011fl\u0131k inovasyonuna yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Agilon Health (AGL), Amerika'n\u0131n ya\u015flanan n\u00fcfusu ile b\u00fcy\u00fck b\u00fcy\u00fcme potansiyeline sahip olan ya\u015fl\u0131lar i\u00e7in de\u011fer odakl\u0131 bak\u0131m\u0131n gelece\u011fini temsil ediyor. Bu sadece ba\u015fka bir sa\u011fl\u0131k hissesi de\u011fil; doktorlar\u0131n hastalara nas\u0131l bak\u0131m sundu\u011funu d\u00f6n\u00fc\u015ft\u00fcrmeye y\u00f6nelik bir bahis ve ayn\u0131 zamanda ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in potansiyel \u00f6d\u00fcller sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"Sa\u011fl\u0131k inovasyonuna yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Agilon Health (AGL), Amerika'n\u0131n ya\u015flanan n\u00fcfusu ile b\u00fcy\u00fck b\u00fcy\u00fcme potansiyeline sahip olan ya\u015fl\u0131lar i\u00e7in de\u011fer odakl\u0131 bak\u0131m\u0131n gelece\u011fini temsil ediyor. Bu sadece ba\u015fka bir sa\u011fl\u0131k hissesi de\u011fil; doktorlar\u0131n hastalara nas\u0131l bak\u0131m sundu\u011funu d\u00f6n\u00fc\u015ft\u00fcrmeye y\u00f6nelik bir bahis ve ayn\u0131 zamanda ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in potansiyel \u00f6d\u00fcller sunuyor."},"body_html":"<h2>\ud83d\udcc8 Agilon Health Hisse Senedi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla Agilon Health (AGL) <strong>1,33 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat hem f\u0131rsat hem de dikkat gerektiren bir hikaye anlat\u0131yor. Ancak takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck kataliz\u00f6r\u00fcn\u00fcz olacak. Bu tarihte AGL \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu raporlar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirmi\u015ftir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 AGL Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>4 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>1,45 $<\/td><td>-%8,3 (tahminlerin alt\u0131nda)<\/td><\/tr> <tr><td>6 May\u0131s 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>2,10 $<\/td><td>-%19,0 (gelir d\u00fc\u015f\u00fc\u015f\u00fc)<\/td><\/tr> <tr><td>\u015eub 2025<\/td><td>\u00d6nceki \u00c7eyrek<\/td><td>3,50 $<\/td><td>-%6,6 (ayl\u0131k performans)<\/td><\/tr> <tr><td>Kas 2024<\/td><td>3. \u00c7eyrek 2024<\/td><td>4,25 $<\/td><td>+%3,2 (\u0131l\u0131ml\u0131 s\u00fcrpriz)<\/td><\/tr> <tr><td>A\u011fu 2024<\/td><td>2. \u00c7eyrek 2024<\/td><td>5,80 $<\/td><td>-%7,1 (rehberlik endi\u015feleri)<\/td><\/tr> <tr><td>May 2024<\/td><td>1. \u00c7eyrek 2024<\/td><td>6,40 $<\/td><td>+%4,7 (g\u00fc\u00e7l\u00fc \u00fcye art\u0131\u015f\u0131)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: AGL son zamanlarda kazan\u00e7 tahminlerini ka\u00e7\u0131rmaya kar\u015f\u0131 a\u015f\u0131r\u0131 hassasiyet g\u00f6sterdi, \u00e7ift haneli y\u00fczdelik hareketler yayg\u0131n hale geldi. Pozitif s\u00fcrprizler h\u0131zl\u0131 y\u00fckseli\u015fler yarat\u0131rken, hayal k\u0131r\u0131kl\u0131klar\u0131 keskin sat\u0131\u015flara yol a\u00e7\u0131yor.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eub-A\u011fu 2025)<\/h3> <p>AGL hisseleri yakla\u015f\u0131k <strong>%62<\/strong> d\u00fc\u015f\u00fc\u015fle bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: 2,99 $-4,08 $ aral\u0131\u011f\u0131 (-%6,6 ayl\u0131k)<\/li> <li><strong>Mart 2025<\/strong>: 2,96 $-4,70 $ aral\u0131\u011f\u0131 (+%38,8 toparlanma)<\/li> <li><strong>Nisan 2025<\/strong>: 3,22 $-5,77 $ aral\u0131\u011f\u0131 (-%10,1 geri \u00e7ekilme)<\/li> <li><strong>May\u0131s-A\u011fustos 2025<\/strong>: Mevcut 1,33 $ seviyelerine istikrarl\u0131 d\u00fc\u015f\u00fc\u015f<\/li> <\/ul> <p><strong>Volatilitenin sebebi nedir?<\/strong> \u015eirket, Medicare geri \u00f6deme zorluklar\u0131, liderlik de\u011fi\u015fiklikleri ve piyasa \u00e7\u0131k\u0131\u015flar\u0131 ile kar\u015f\u0131 kar\u015f\u0131ya; bu durum yat\u0131r\u0131mc\u0131 g\u00fcvenini sarst\u0131 ancak platformda 605.000 \u00fcye say\u0131s\u0131n\u0131 koruyor.<\/p> <h3>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h3> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 2,50-3,50 $ (potansiyel %88-163 y\u00fckseli\u015f) \u2192 <strong>TUT<\/strong> (3. \u00e7eyrek kazan\u00e7 a\u00e7\u0131klamas\u0131 beklenmeli)<\/li> <li><strong>2026 Tahmini<\/strong>: 3,50-5,00 $ (uygulama iyile\u015firse toparlanma d\u00f6nemi)<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 6,00-8,00 $ (de\u011fer odakl\u0131 bak\u0131m benimsenmesi h\u0131zlan\u0131yor)<\/li> <li><strong>2030 Vizyonu<\/strong>: 10,00 $+ (ya\u015flanan n\u00fcfus demografik avantajlar\u0131)<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: \u015eu anda y\u00fcksek riskli, y\u00fcksek potansiyelli bir f\u0131rsat. Daha iyi giri\u015f noktalar\u0131 muhtemelen 3. \u00e7eyrek kazan\u00e7lar\u0131ndan sonra olacak.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Liderlik belirsizli\u011fi<\/strong>: CEO Steven Sell'in A\u011fustos 2025'te ani ayr\u0131l\u0131\u011f\u0131 y\u00f6neti\u015fim endi\u015feleri yaratt\u0131<\/li> <li><strong>Rehberlik iptali<\/strong>: \u015eirket 2025 tahminlerini geri \u00e7ekti, belirsizli\u011fi art\u0131rd\u0131<\/li> <li><strong>Reg\u00fclasyon riski<\/strong>: Medicare geri \u00f6deme de\u011fi\u015fiklikleri do\u011frudan geliri etkiliyor<\/li> <li><strong>Y\u00fcksek volatilite<\/strong>: %43,7 ayl\u0131k d\u00fc\u015f\u00fc\u015fler a\u015f\u0131r\u0131 fiyat hassasiyetini g\u00f6steriyor<\/li> <li><strong>Piyasa \u00e7\u0131k\u0131\u015flar\u0131<\/strong>: Son gelir d\u00fc\u015f\u00fc\u015flerine katk\u0131da bulunuyor<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Nakit g\u00fcc\u00fc<\/strong>: 369 milyon $ nakit rezervi istikrar sa\u011fl\u0131yor<\/li> <li><strong>D\u00fc\u015f\u00fck bor\u00e7<\/strong>: Sadece 35 milyon $ toplam bor\u00e7 finansal esneklik sunuyor<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: De\u011fer odakl\u0131 bak\u0131m y\u0131ll\u0131k %15 b\u00fcy\u00fcyor<\/li> <li><strong>Doktor a\u011f\u0131<\/strong>: 30 toplulukta 2.200'den fazla birinci basamak hekimi<\/li> <li><strong>Analist iyimserli\u011fi<\/strong>: Ortalama 3,16 $ fiyat hedefi %137 y\u00fckseli\u015f potansiyeli g\u00f6steriyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>A\u00e7\u0131kl\u0131k bekleyin<\/strong>: 6 Kas\u0131m kazan\u00e7lar\u0131 \u00e7ok ihtiya\u00e7 duyulan y\u00f6n\u00fc sa\u011flayacak\u2014sab\u0131r kazand\u0131r\u0131r<\/li> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Al\u0131m yapacaksan\u0131z, k\u00fc\u00e7\u00fck pozisyonlarla dolar maliyeti ortalamas\u0131 kullan\u0131n<\/li> <li><strong>Stop-loss koyun<\/strong>: Volatilite nedeniyle sermayenizi s\u0131k\u0131 risk y\u00f6netimi ile koruyun<\/li> <li><strong>Liderli\u011fi izleyin<\/strong>: Kal\u0131c\u0131 CEO atamas\u0131 olumlu bir kataliz\u00f6r olabilir<\/li> <\/ol> <p>Esprili yorum: \"\u015eu anda AGL ticareti yapmak, anestezi olmadan ameliyat yapmak gibi\u2014ba\u015farabilirsiniz ama gereken ac\u0131 tolerans\u0131 ola\u011fan\u00fcst\u00fc!\"<\/p> <h2>\u2705 Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ticaret platformu se\u00e7in<\/td><td>NYSE eri\u015fimi ve par\u00e7al\u0131 hisse imkan\u0131 sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Risk uygun sermaye ile ba\u015flay\u0131n (\u00f6nerilen 100-500 $ ba\u015flang\u0131\u00e7 testi)<\/td><\/tr> <tr><td>3<\/td><td>\"AGL\" sembol\u00fcn\u00fc aray\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Volatilite nedeniyle limitli emirler \u00f6nerilir\u2014\u00f6deyece\u011finiz maksimum fiyat\u0131 belirleyin<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretleri ve emir detaylar\u0131n\u0131 sonland\u0131rmadan \u00f6nce kontrol edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Sa\u011fl\u0131k Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>Pocket Option sa\u011fl\u0131k hisselerine yat\u0131r\u0131m yapmay\u0131 benzersiz avantajlarla kolayla\u015ft\u0131r\u0131r:<\/p> <ul> <li><strong>Minimum depozito: 5 $<\/strong> \u2014 AGL stratejilerini d\u00fc\u015f\u00fck riskle test edin<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> \u2014 Tek belge KYC ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> \u2014 Karlar\u0131n\u0131za birden fazla \u00f6deme y\u00f6ntemiyle eri\u015fin<\/li> <li><strong>Par\u00e7al\u0131 hisse<\/strong> \u2014 Tam 1,33 $ hisse almadan k\u0131smi AGL hisseleri sat\u0131n al\u0131n<\/li> <\/ul> <p>AGL gibi volatil hisseleri ke\u015ffeden yeni ba\u015flayanlar i\u00e7in Pocket Option d\u00fc\u015f\u00fck bariyerleri ve risk y\u00f6netimi ara\u00e7lar\u0131 ile ideal bir ba\u015flang\u0131\u00e7 ortam\u0131 sunar.<\/p> <h2>\ud83c\udf0d 2025'te Agilon Health: Ya\u015fl\u0131 Bak\u0131m\u0131n\u0131 D\u00f6n\u00fc\u015ft\u00fcrmek<\/h2> <p>Agilon Health, sa\u011fl\u0131k inovasyonu ve demografik trendlerin kesi\u015fiminde faaliyet g\u00f6sterir. \u015eirket, ba\u011f\u0131ms\u0131z doktorlarla ortakl\u0131k kurarak hizmet ba\u015f\u0131na \u00fccret modelinden, hastalar\u0131 sa\u011fl\u0131kl\u0131 tutmaya dayal\u0131 de\u011fer odakl\u0131 bak\u0131m modellerine ge\u00e7i\u015f yap\u0131yor.<\/p> <p><strong>Mevcut Piyasa Konumu<\/strong>:<\/p> <ul> <li>Doktor ortakl\u0131klar\u0131 arac\u0131l\u0131\u011f\u0131yla 605.000 \u00fcyeyi y\u00f6netiyor<\/li> <li>30 toplulukta 2.200'den fazla birinci basamak hekimi ile \u00e7al\u0131\u015f\u0131yor<\/li> <li>Son zorluklara ra\u011fmen 369 milyon $ nakit pozisyonunu koruyor<\/li> <li>De\u011fer odakl\u0131 Medicare Advantage bak\u0131m\u0131na ge\u00e7i\u015fte lider konumda<\/li> <\/ul> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Agilon'un doktor ortaklar\u0131, kanser taramalar\u0131 ve ila\u00e7 uyumu i\u00e7in be\u015f y\u0131ld\u0131zl\u0131 derecelendirmeler al\u0131yor\u2014bu, daha iyi bak\u0131m uyumunun sa\u011fl\u0131k sonu\u00e7lar\u0131n\u0131 iyile\u015ftirirken maliyetleri potansiyel olarak d\u00fc\u015f\u00fcrd\u00fc\u011f\u00fcn\u00fc kan\u0131tl\u0131yor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Agilon Health Hisse Senedi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla Agilon Health (AGL) <strong>1,33 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat hem f\u0131rsat hem de dikkat gerektiren bir hikaye anlat\u0131yor. Ancak takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck kataliz\u00f6r\u00fcn\u00fcz olacak. Bu tarihte AGL \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu raporlar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirmi\u015ftir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 AGL Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>1,45 $<\/td>\n<td>-%8,3 (tahminlerin alt\u0131nda)<\/td>\n<\/tr>\n<tr>\n<td>6 May\u0131s 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>2,10 $<\/td>\n<td>-%19,0 (gelir d\u00fc\u015f\u00fc\u015f\u00fc)<\/td>\n<\/tr>\n<tr>\n<td>\u015eub 2025<\/td>\n<td>\u00d6nceki \u00c7eyrek<\/td>\n<td>3,50 $<\/td>\n<td>-%6,6 (ayl\u0131k performans)<\/td>\n<\/tr>\n<tr>\n<td>Kas 2024<\/td>\n<td>3. \u00c7eyrek 2024<\/td>\n<td>4,25 $<\/td>\n<td>+%3,2 (\u0131l\u0131ml\u0131 s\u00fcrpriz)<\/td>\n<\/tr>\n<tr>\n<td>A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek 2024<\/td>\n<td>5,80 $<\/td>\n<td>-%7,1 (rehberlik endi\u015feleri)<\/td>\n<\/tr>\n<tr>\n<td>May 2024<\/td>\n<td>1. \u00c7eyrek 2024<\/td>\n<td>6,40 $<\/td>\n<td>+%4,7 (g\u00fc\u00e7l\u00fc \u00fcye art\u0131\u015f\u0131)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: AGL son zamanlarda kazan\u00e7 tahminlerini ka\u00e7\u0131rmaya kar\u015f\u0131 a\u015f\u0131r\u0131 hassasiyet g\u00f6sterdi, \u00e7ift haneli y\u00fczdelik hareketler yayg\u0131n hale geldi. Pozitif s\u00fcrprizler h\u0131zl\u0131 y\u00fckseli\u015fler yarat\u0131rken, hayal k\u0131r\u0131kl\u0131klar\u0131 keskin sat\u0131\u015flara yol a\u00e7\u0131yor.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eub-A\u011fu 2025)<\/h3>\n<p>AGL hisseleri yakla\u015f\u0131k <strong>%62<\/strong> d\u00fc\u015f\u00fc\u015fle bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: 2,99 $-4,08 $ aral\u0131\u011f\u0131 (-%6,6 ayl\u0131k)<\/li>\n<li><strong>Mart 2025<\/strong>: 2,96 $-4,70 $ aral\u0131\u011f\u0131 (+%38,8 toparlanma)<\/li>\n<li><strong>Nisan 2025<\/strong>: 3,22 $-5,77 $ aral\u0131\u011f\u0131 (-%10,1 geri \u00e7ekilme)<\/li>\n<li><strong>May\u0131s-A\u011fustos 2025<\/strong>: Mevcut 1,33 $ seviyelerine istikrarl\u0131 d\u00fc\u015f\u00fc\u015f<\/li>\n<\/ul>\n<p><strong>Volatilitenin sebebi nedir?<\/strong> \u015eirket, Medicare geri \u00f6deme zorluklar\u0131, liderlik de\u011fi\u015fiklikleri ve piyasa \u00e7\u0131k\u0131\u015flar\u0131 ile kar\u015f\u0131 kar\u015f\u0131ya; bu durum yat\u0131r\u0131mc\u0131 g\u00fcvenini sarst\u0131 ancak platformda 605.000 \u00fcye say\u0131s\u0131n\u0131 koruyor.<\/p>\n<h3>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h3>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 2,50-3,50 $ (potansiyel %88-163 y\u00fckseli\u015f) \u2192 <strong>TUT<\/strong> (3. \u00e7eyrek kazan\u00e7 a\u00e7\u0131klamas\u0131 beklenmeli)<\/li>\n<li><strong>2026 Tahmini<\/strong>: 3,50-5,00 $ (uygulama iyile\u015firse toparlanma d\u00f6nemi)<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 6,00-8,00 $ (de\u011fer odakl\u0131 bak\u0131m benimsenmesi h\u0131zlan\u0131yor)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 10,00 $+ (ya\u015flanan n\u00fcfus demografik avantajlar\u0131)<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: \u015eu anda y\u00fcksek riskli, y\u00fcksek potansiyelli bir f\u0131rsat. Daha iyi giri\u015f noktalar\u0131 muhtemelen 3. \u00e7eyrek kazan\u00e7lar\u0131ndan sonra olacak.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Liderlik belirsizli\u011fi<\/strong>: CEO Steven Sell&#8217;in A\u011fustos 2025&#8217;te ani ayr\u0131l\u0131\u011f\u0131 y\u00f6neti\u015fim endi\u015feleri yaratt\u0131<\/li>\n<li><strong>Rehberlik iptali<\/strong>: \u015eirket 2025 tahminlerini geri \u00e7ekti, belirsizli\u011fi art\u0131rd\u0131<\/li>\n<li><strong>Reg\u00fclasyon riski<\/strong>: Medicare geri \u00f6deme de\u011fi\u015fiklikleri do\u011frudan geliri etkiliyor<\/li>\n<li><strong>Y\u00fcksek volatilite<\/strong>: %43,7 ayl\u0131k d\u00fc\u015f\u00fc\u015fler a\u015f\u0131r\u0131 fiyat hassasiyetini g\u00f6steriyor<\/li>\n<li><strong>Piyasa \u00e7\u0131k\u0131\u015flar\u0131<\/strong>: Son gelir d\u00fc\u015f\u00fc\u015flerine katk\u0131da bulunuyor<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Nakit g\u00fcc\u00fc<\/strong>: 369 milyon $ nakit rezervi istikrar sa\u011fl\u0131yor<\/li>\n<li><strong>D\u00fc\u015f\u00fck bor\u00e7<\/strong>: Sadece 35 milyon $ toplam bor\u00e7 finansal esneklik sunuyor<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: De\u011fer odakl\u0131 bak\u0131m y\u0131ll\u0131k %15 b\u00fcy\u00fcyor<\/li>\n<li><strong>Doktor a\u011f\u0131<\/strong>: 30 toplulukta 2.200&#8217;den fazla birinci basamak hekimi<\/li>\n<li><strong>Analist iyimserli\u011fi<\/strong>: Ortalama 3,16 $ fiyat hedefi %137 y\u00fckseli\u015f potansiyeli g\u00f6steriyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>A\u00e7\u0131kl\u0131k bekleyin<\/strong>: 6 Kas\u0131m kazan\u00e7lar\u0131 \u00e7ok ihtiya\u00e7 duyulan y\u00f6n\u00fc sa\u011flayacak\u2014sab\u0131r kazand\u0131r\u0131r<\/li>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Al\u0131m yapacaksan\u0131z, k\u00fc\u00e7\u00fck pozisyonlarla dolar maliyeti ortalamas\u0131 kullan\u0131n<\/li>\n<li><strong>Stop-loss koyun<\/strong>: Volatilite nedeniyle sermayenizi s\u0131k\u0131 risk y\u00f6netimi ile koruyun<\/li>\n<li><strong>Liderli\u011fi izleyin<\/strong>: Kal\u0131c\u0131 CEO atamas\u0131 olumlu bir kataliz\u00f6r olabilir<\/li>\n<\/ol>\n<p>Esprili yorum: &#8220;\u015eu anda AGL ticareti yapmak, anestezi olmadan ameliyat yapmak gibi\u2014ba\u015farabilirsiniz ama gereken ac\u0131 tolerans\u0131 ola\u011fan\u00fcst\u00fc!&#8221;<\/p>\n<h2>\u2705 Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ticaret platformu se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve par\u00e7al\u0131 hisse imkan\u0131 sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Risk uygun sermaye ile ba\u015flay\u0131n (\u00f6nerilen 100-500 $ ba\u015flang\u0131\u00e7 testi)<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;AGL&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Volatilite nedeniyle limitli emirler \u00f6nerilir\u2014\u00f6deyece\u011finiz maksimum fiyat\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretleri ve emir detaylar\u0131n\u0131 sonland\u0131rmadan \u00f6nce kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Sa\u011fl\u0131k Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>Pocket Option sa\u011fl\u0131k hisselerine yat\u0131r\u0131m yapmay\u0131 benzersiz avantajlarla kolayla\u015ft\u0131r\u0131r:<\/p>\n<ul>\n<li><strong>Minimum depozito: 5 $<\/strong> \u2014 AGL stratejilerini d\u00fc\u015f\u00fck riskle test edin<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> \u2014 Tek belge KYC ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> \u2014 Karlar\u0131n\u0131za birden fazla \u00f6deme y\u00f6ntemiyle eri\u015fin<\/li>\n<li><strong>Par\u00e7al\u0131 hisse<\/strong> \u2014 Tam 1,33 $ hisse almadan k\u0131smi AGL hisseleri sat\u0131n al\u0131n<\/li>\n<\/ul>\n<p>AGL gibi volatil hisseleri ke\u015ffeden yeni ba\u015flayanlar i\u00e7in Pocket Option d\u00fc\u015f\u00fck bariyerleri ve risk y\u00f6netimi ara\u00e7lar\u0131 ile ideal bir ba\u015flang\u0131\u00e7 ortam\u0131 sunar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Agilon Health: Ya\u015fl\u0131 Bak\u0131m\u0131n\u0131 D\u00f6n\u00fc\u015ft\u00fcrmek<\/h2>\n<p>Agilon Health, sa\u011fl\u0131k inovasyonu ve demografik trendlerin kesi\u015fiminde faaliyet g\u00f6sterir. \u015eirket, ba\u011f\u0131ms\u0131z doktorlarla ortakl\u0131k kurarak hizmet ba\u015f\u0131na \u00fccret modelinden, hastalar\u0131 sa\u011fl\u0131kl\u0131 tutmaya dayal\u0131 de\u011fer odakl\u0131 bak\u0131m modellerine ge\u00e7i\u015f yap\u0131yor.<\/p>\n<p><strong>Mevcut Piyasa Konumu<\/strong>:<\/p>\n<ul>\n<li>Doktor ortakl\u0131klar\u0131 arac\u0131l\u0131\u011f\u0131yla 605.000 \u00fcyeyi y\u00f6netiyor<\/li>\n<li>30 toplulukta 2.200&#8217;den fazla birinci basamak hekimi ile \u00e7al\u0131\u015f\u0131yor<\/li>\n<li>Son zorluklara ra\u011fmen 369 milyon $ nakit pozisyonunu koruyor<\/li>\n<li>De\u011fer odakl\u0131 Medicare Advantage bak\u0131m\u0131na ge\u00e7i\u015fte lider konumda<\/li>\n<\/ul>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Agilon&#8217;un doktor ortaklar\u0131, kanser taramalar\u0131 ve ila\u00e7 uyumu i\u00e7in be\u015f y\u0131ld\u0131zl\u0131 derecelendirmeler al\u0131yor\u2014bu, daha iyi bak\u0131m uyumunun sa\u011fl\u0131k sonu\u00e7lar\u0131n\u0131 iyile\u015ftirirken maliyetleri potansiyel olarak d\u00fc\u015f\u00fcrd\u00fc\u011f\u00fcn\u00fc kan\u0131tl\u0131yor.<\/p>\n"},"faq":[{"question":"Agilon Health hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"AGL\" sembol\u00fcn\u00fc aray\u0131n, limitli emir verin ve i\u015flemi onaylay\u0131n."},{"question":"AGL hissesinin mevcut fiyat\u0131 nedir?","answer":"25 A\u011fustos 2025 itibar\u0131yla AGL hissesi 1,33 $ seviyesinde i\u015flem g\u00f6rmektedir."},{"question":"AGL hissesi i\u00e7in riskler nelerdir?","answer":"Liderlik belirsizli\u011fi, rehberlik iptali, reg\u00fclasyon de\u011fi\u015fiklikleri, y\u00fcksek volatilite ve piyasa \u00e7\u0131k\u0131\u015flar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"AGL hissesi i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 2,50-3,50 $ aras\u0131, 2030'da ise 10,00 $ ve \u00fczeri fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar AGL hissesi al\u0131rken nelere dikkat etmeli?","answer":"Kazan\u00e7 a\u00e7\u0131klamalar\u0131n\u0131 beklemek, k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flamak, stop-loss kullanmak ve liderlik geli\u015fmelerini takip etmek \u00f6nemlidir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Agilon Health hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"AGL\" sembol\u00fcn\u00fc aray\u0131n, limitli emir verin ve i\u015flemi onaylay\u0131n."},{"question":"AGL hissesinin mevcut fiyat\u0131 nedir?","answer":"25 A\u011fustos 2025 itibar\u0131yla AGL hissesi 1,33 $ seviyesinde i\u015flem g\u00f6rmektedir."},{"question":"AGL hissesi i\u00e7in riskler nelerdir?","answer":"Liderlik belirsizli\u011fi, rehberlik iptali, reg\u00fclasyon de\u011fi\u015fiklikleri, y\u00fcksek volatilite ve piyasa \u00e7\u0131k\u0131\u015flar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"AGL hissesi i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 2,50-3,50 $ aras\u0131, 2030'da ise 10,00 $ ve \u00fczeri fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar AGL hissesi al\u0131rken nelere dikkat etmeli?","answer":"Kazan\u00e7 a\u00e7\u0131klamalar\u0131n\u0131 beklemek, k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flamak, stop-loss kullanmak ve liderlik geli\u015fmelerini takip etmek \u00f6nemlidir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T11:08:26+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T11:08:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/\",\"name\":\"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-25T11:08:26+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/","og_locale":"tr_TR","og_type":"article","og_title":"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T11:08:26+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T11:08:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/","name":"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-25T11:08:26+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-agilon-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Agilon Health, Inc. (AGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Agilon Health, Inc. (AGL) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":347030,"slug":"how-to-buy-agilon-health","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu agilon health, inc. (AGL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu agilon health, inc. (AGL)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-agilon-health\/"},"pt_AA":{"locale":"pt_AA","id":347034,"slug":"how-to-buy-agilon-health","post_title":"Como comprar a\u00e7\u00f5es da agilon health, inc. (AGL) - Investimento em a\u00e7\u00f5es da agilon health, inc. (AGL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-agilon-health\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/347032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=347032"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/347032\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=347032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=347032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=347032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}